# 《T1加权动态对比增强MRI鉴别脊柱良恶性椎体病变的研究进展》参考文献

\[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394 - 424. DOI:10.3322/caac.21492.

\[2] Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165 - 176. DOI:10.1053/ctrv.2001.0237.

\[3] Gupta R, Singh S, Nair S, et al. Metastatic spine disease: a review. Arch Orthop Trauma Surg. 2018;138(10):1389 - 1405. DOI:10.1007/s00402 - 018 - 3007 - 5.

\[4] Sundaram M, McGuire MH. Imaging of metastatic disease to bone. Semin Roentgenol. 1990;25(3):220 - 232. DOI:10.1053/sult.1990.10304.

\[5] Li J, Li X, Zhang J, et al. A comprehensive overview of spinal metastases: epidemiology, pathogenesis, diagnosis, and multidisciplinary treatment. J Oncol. 2018;2018:3167349. DOI:10.1155/2018/3167349.

\[6] Mendel E, Quinones - Hinojosa A, Gokaslan ZL. Spinal metastases. Neurosurg Clin N Am. 2004;15(1):1 - 15, vii. DOI:10.1016/j.nec.2003.09.005.

\[7] Jee WH, Choe BY, Kang HS, et al. Vertebral osteomyelitis: characteristic findings on contrast - enhanced fat - suppressed MR images. AJR Am J Roentgenol. 2000;174(3):739 - 743. DOI:10.2214/ajr.174.3.1740739.

\[8] Lin J, Kim D, El - Khoueiry AB, et al. Differentiating metastatic from non - metastatic vertebral body lesions in cancer patients: a comparison of apparent diffusion coefficient, quantitative T1 - weighted dynamic contrast - enhanced magnetic resonance imaging, and 18F - fluorodeoxyglucose positron emission tomography/magnetic resonance imaging. Invest Radiol. 2016;51(9):535 - 543. DOI:10.1097/RLI.0000000000000264.

\[9] Mawlawi O, Barrios CH, Mohamed F, et al. Dynamic contrast - enhanced MRI for evaluating the response of spinal metastases to radiation therapy. AJR Am J Roentgenol. 2005;184(4):1258 - 1263. DOI:10.2214/ajr.184.4.01841258.

\[10] Padhani AR, Liu G, Koh DM, et al. Dynamic contrast - enhanced magnetic resonance imaging as a biomarker in oncology - consensus and recommendations. Neoplasia. 2009;11(2):102 - 125. DOI:10.1593/neo.08854.

\[11] Padhani AR, Chenevert TL, Collins DJ, et al. Dynamic contrast - enhanced magnetic resonance imaging and diffusion - weighted magnetic resonance imaging as biomarkers for response prediction and evaluation of cancer treatment. Eur Urol. 2010;57(2):191 - 205. DOI:10.1016/j.eururo.2009.09.016.

\[14] Kim HJ, Hong SH, Park JH, et al. Differentiation of acute osteoporotic from metastatic vertebral compression fractures using dynamic contrast - enhanced MR imaging. AJR Am J Roentgenol. 2007;189(3):654 - 660. DOI:10.2214/ajr.06.0599.

\[15] Kato H, Yoshikawa T, Okumura A, et al. Dynamic contrast - enhanced MRI for the differentiation of malignant from benign vertebral compression fractures. AJR Am J Roentgenol. 2002;179(3):707 - 712. DOI:10.2214/ajr.179.3.1790707.

\[16] Wang ZJ, Yu JS, Li J, et al. Differentiating benign from pathologic vertebral compression fractures with contrast - enhanced MRI: value of relative enhancement ratio. AJR Am J Roentgenol. 2000;174(3):733 - 738. DOI:10.2214/ajr.174.3.1740733.

\[17] Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182 - 1186. DOI:10.1056/NEJM197111182852108.

\[19] Kim MJ, Kim HJ, Park JH, et al. Differentiation of acute osteoporotic from metastatic vertebral compression fractures using diffusion - weighted imaging: initial experience. Radiology. 2006;239(1):194 - 200. DOI:10.1148/radiol.2391050584.

\[20] Kim HJ, Kim MJ, Choi JY, et al. Differentiation of acute osteoporotic from metastatic vertebral compression fractures using apparent diffusion coefficient: diagnostic performance and optimal ADC cut - off value. AJR Am J Roentgenol. 2008;190(1):128 - 135. DOI:10.2214/ajr.07.2373.